Rhaeos a Finalist at the 2018 Congress of Neurological Surgeons Innovator of the Year Award

OCTOBER 5, 2018
PRESS RELEASE: Rhaeos a Finalist at the 2018 Congress of Neurological Surgeons Innovator of the Year Award
EVANSTON, Illinois, October 5th, 2018 – Rhaeos: The Wearable Shunt Monitor, has been chosen as one of the top four finalists for the 2018 Innovator of the Year award at the annual Congress of Neurological Surgeons meeting in Houston, TX. The technology underlying Rhaeos was developed through interdisciplinary efforts between neurological surgeons at Northwestern Memorial Hospital and materials scientists led by John A. Rogers, PhD of the Simpson-Querrey Institute for Bio-Integrated Electronics.
Rhaeos will be presented by Amit Ayer, MD MBA in the CNS Xperience Lounge on Monday, October 8, 2018 from 2:00-2:10PM. Voting for the Top Innovator will be done by meeting attendees on Tuesday, and the winner will be announced at 10:48 AM during Wednesday’s General Scientific Session.
Rhaeos, Inc. was founded in 2018 after years of interdisciplinary efforts between the Rogers group and neurosurgeons at Northwestern Memorial Hospital. After promising initial benchtop experiments incorporating flexible, bioelectronics in thermal flow measurements, this technology was translated to patients in a small, proof-of-concept clinical study in late 2017. Initial work was awarded a Dixon Translational Research award from the Northwestern University Clinical and Translational Science Institute under the leadership of Dr. Matthew Potts. A preliminary patent was filed in May 2018 by Northwestern University’s Innovation and New Ventures Office.
This wearable biosensor permits the dynamic evaluation of patients with indwelling ventricular shunts. For the first time, personalized data of individual patient cerebrospinal fluid hydrodynamics may be wirelessly transmitted to a mobile application for clinician or academic use. This has the potential to mitigate the substantive costs associated with expensive, inaccurate, and painful diagnostic testing.
“This technology brings fundamental advances in soft electronic materials to the important problem of hydrocephalus diagnostics,” said Siddharth Krishnan, PhD candidate at the Rogers group, a fundamental contributor to the academic work. “I’m hopeful we can make a difference in the lives of patients and their families.”
Rhaeos, Inc.is a wearable soft electronic ventricular shunt monitor for use in the care of hydrocephalic patients.
If you would like more information about this topic, please email rhaeosinc@gmail.com